Abstract:Selecting a course of treatment in psychiatry remains a trial-and-error process, and this long-standing clinical challenge has prompted an increased focus on predictive models of treatment response using machine learning techniques. Electroencephalography (EEG) represents a cost-effective and scalable potential measure to predict treatment response to major depressive disorder. We performed separate meta-analyses to determine the ability of models to distinguish between responders and non-responders using EEG across treatments, as well as a performed subgroup analysis of response to transcranial magnetic stimulation (rTMS), and antidepressants (Registration Number: CRD42021257477) in Major Depressive Disorder by searching PubMed, Scopus, and Web of Science for articles published between January 1960 and February 2022. We included 15 studies that predicted treatment responses among patients with major depressive disorder using machine-learning techniques. Within a random-effects model with a restricted maximum likelihood estimator comprising 758 patients, the pooled accuracy across studies was 83.93% (95% CI: 78.90–89.29), with an Area-Under-the-Curve (AUC) of 0.850 (95% CI: 0.747–0.890), and partial AUC of 0.779. The average sensitivity and specificity across models were 77.96% (95% CI: 60.05–88.70), and 84.60% (95% CI: 67.89–92.39), respectively. In a subgroup analysis, greater performance was observed in predicting response to rTMS (Pooled accuracy: 85.70% (95% CI: 77.45–94.83), Area-Under-the-Curve (AUC): 0.928, partial AUC: 0.844), relative to antidepressants (Pooled accuracy: 81.41% (95% CI: 77.45–94.83, AUC: 0.895, pAUC: 0.821). Furthermore, across all meta-analyses, the specificity (true negatives) of EEG models was greater than the sensitivity (true positives), suggesting that EEG models thus far better identify non-responders than responders to treatment in MDD. Studies varied widely in important features across models, although relevant features included absolute and relative power in frontal and temporal electrodes, measures of connectivity, and asymmetry across hemispheres. Predictive models of treatment response using EEG hold promise in major depressive disorder, although there is a need for prospective model validation in independent datasets, and a greater emphasis on replicating physiological markers. Crucially, standardization in cut-off values and clinical scales for defining clinical response and non-response will aid in the reproducibility of findings and the clinical utility of predictive models. Furthermore, several models thus far have used data from open-label trials with small sample sizes and evaluated performance in the absence of training and testing sets, which increases the risk of statistical overfitting. Large consortium studies are required to establish predictive signatures of treatment response using EEG, and better elucidate the replicability of specific markers. Additionally, it is speculated that greater performance was observed in rTMS models, since EEG is assessing neural networks more likely to be directly targeted by rTMS, comprising electrical activity primarily near the surface of the cortex. Prospectively, there is a need for models that examine the comparative effectiveness of multiple treatments across the same patients. However, this will require a thoughtful consideration towards cumulative treatment effects, and whether washout periods between treatments should be utilised. Regardless, longitudinal cross-over trials comparing multiple treatments across the same group of patients will be an important prerequisite step to both facilitate precision psychiatry and identify generalizable physiological predictors of response between and across treatment options.

Learning Optimal Biomarker-Guided Treatment Policy for Chronic Disorders

Learning optimal biomarker‐guided treatment policy for chronic disorders

Multiband EEG signature decoded using machine learning for predicting rTMS treatment response in major depression

Assisting Schizophrenia Diagnosis Using Clinical Electroencephalography and Interpretable Graph Neural Networks: a Real-World and Cross-Site Study

Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis

Using deep learning and pretreatment EEG to predict response to sertraline, bupropion, and placebo

Improving Brain E-Health Services via High-Performance EEG Classification With Grouping Bayesian Optimization

Predictors for drug effects with brain disease: Shed new light from EEG parameters to brain connectomics

Prediction of Treatment Outcome to Transcranial Direct Current Stimulation in Major Depression Based on Deep Learning of EEG Data

Electroencephalographic Network Topologies Predict Antidepressant Responses in Patients With Major Depressive Disorder

Deep learning based treatment remission prediction to transcranial direct current stimulation in bipolar depression using EEG power spectral density

Machine learning-based classification using electroencephalographic multi-paradigms between drug-naïve patients with depression and healthy controls

Prediction of Clinical Outcomes With EEG Microstate in Patients With Major Depressive Disorder

Machine learning approaches and non-linear processing of extracted components in frontal region to predict rTMS treatment response in major depressive disorder

Prediction of antidepressant responses to non-invasive brain stimulation using frontal electroencephalogram signals: Cross-dataset comparisons and validation

Local and large-scale resting-state oscillatory dysfunctions for early antidepressant response prediction in major depressive disorder

EEG-based major depressive disorder recognition by selecting discriminative features via stochastic search

QEEG Biomarkers for ECT Treatment Response in Schizophrenia

Machine Learning in Electroconvulsive Therapy

An Optimal Channel Selection for EEG-Based Depression Detection via Kernel-Target Alignment

An Electroencephalographic Signature Predicts Antidepressant Response in Major Depression